| IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology KT Steeve, P Marc, T Sandrine, H Dominique, F Yannick Cytokine & growth factor reviews 15 (1), 49-60, 2004 | 1275 | 2004 |
| Primer on the metabolic bone diseases and disorders of mineral metabolism MJ Favus Primer on the metabolic bone diseases and disorders of mineral metabolism …, 1996 | 1103 | 1996 |
| The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling S Theoleyre, Y Wittrant, SK Tat, Y Fortun, F Redini, D Heymann Cytokine & growth factor reviews 15 (6), 457-475, 2004 | 911 | 2004 |
| Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/β-tricalcium phosphate ratios S Yamada, D Heymann, JM Bouler, G Daculsi Biomaterials 18 (15), 1037-1041, 1997 | 593 | 1997 |
| Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling P Guihard, Y Danger, B Brounais, E David, R Brion, J Delecrin, ... Stem cells 30 (4), 762-772, 2012 | 512 | 2012 |
| Human breast cancer cells educate macrophages toward the M2 activation status S Sousa, R Brion, M Lintunen, P Kronqvist, J Sandholm, J Mönkkönen, ... Breast cancer research 17, 1-14, 2015 | 443 | 2015 |
| Autophagy in osteoblasts is involved in mineralization and bone homeostasis M Nollet, S Santucci-Darmanin, V Breuil, R Al-Sahlanee, C Cros, M Topi, ... Autophagy 10 (11), 1965-1977, 2014 | 414 | 2014 |
| Mechanisms of bone repair and regeneration F Deschaseaux, L Sensébé, D Heymann Trends in molecular medicine 15 (9), 417-429, 2009 | 408 | 2009 |
| Recent advances in TGF-β effects on chondrocyte metabolism: potential therapeutic roles of TGF-β in cartilage disorders E Grimaud, D Heymann, F Rédini Cytokine & growth factor reviews 13 (3), 241-257, 2002 | 388 | 2002 |
| Receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis E Grimaud, L Soubigou, S Couillaud, P Coipeau, A Moreau, N Passuti, ... The American journal of pathology 163 (5), 2021-2031, 2003 | 374 | 2003 |
| Cancer stem cells in osteosarcoma HK Brown, M Tellez-Gabriel, D Heymann Cancer letters 386, 189-195, 2017 | 300 | 2017 |
| Osteosarcoma HC Beird, SS Bielack, AM Flanagan, J Gill, D Heymann, KA Janeway, ... Nature reviews Disease primers 8 (1), 77, 2022 | 294 | 2022 |
| RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis Y Wittrant, S Théoleyre, C Chipoy, M Padrines, F Blanchard, D Heymann, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1704 (2), 49-57, 2004 | 288 | 2004 |
| Osteoclastic acidification pathways during bone resorption AV Rousselle, D Heymann Bone 30 (4), 533-540, 2002 | 277 | 2002 |
| Current therapeutic strategies and novel approaches in osteosarcoma K Ando, MF Heymann, V Stresing, K Mori, F Rédini, D Heymann Cancers 5 (2), 591-616, 2013 | 272 | 2013 |
| Circulating tumor cells: a review of non–EpCAM-based approaches for cell enrichment and isolation MT Gabriel, LR Calleja, A Chalopin, B Ory, D Heymann Clinical chemistry 62 (4), 571-581, 2016 | 264 | 2016 |
| Sarcoma treatment in the era of molecular medicine TGP Grünewald, M Alonso, S Avnet, A Banito, S Burdach, F Cidre‐Aranaz, ... EMBO molecular medicine 12 (11), e11131, 2020 | 236 | 2020 |
| gp130 Cytokine family and bone cells D Heymann, AV Rousselle Cytokine 12 (10), 1455-1468, 2000 | 234 | 2000 |
| The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma MF Heymann, F Lézot, D Heymann Cellular immunology 343, 103711, 2019 | 221 | 2019 |
| RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases M Baud’Huin, F Lamoureux, L Duplomb, F Rédini, D Heymann Cellular and molecular life sciences 64, 2334-2350, 2007 | 216 | 2007 |
